Lyell Immunopharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Lyell Immunopharma Inc: Is Infosys Ltd. worth buying?
Item: Lyell Immunopharma Inc
Rating: 1.62733325
Author: Trendlyne DVM scores

about

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...

21.21 0.40 (1.92%)

52.87% Fall from 52W High

88,851

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.8 / 100

Technically Neutral

55.3 / 100

1Yr Price target upside is 53%

4 analysts

Lyell Immunopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lyell Immunopharma Inc Live Stock Price Today, Share Analysis and Chart

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. ...

52.87% Fall from 52W High

SWOT Analysis

Lyell Immunopharma Inc Live Price Chart